Respiri (ASX:RSH) is taking a big step forward with an agreement for its Pharmacy Catalyst members to sell its wheezo … Read More
The post Pharmacists to begin recommending Respiri’s wheezo asthma management device appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.